FDA Import Refusal SCS-3161205-6/11/4 — SUN PHARMACEUTICAL INDUSTRIES
The FDA refused shipment SCS-3161205-6/11/4 from SUN PHARMACEUTICAL INDUSTRIES (India) on Dec 18, 2020. The refused product falls under Drugs and Biologics — CIPROFLOXACIN (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC). Cited charges: 118,3280 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Dec 18, 2020
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61FCY54 CIPROFLOXACIN (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC)
- Charges
- 118,3280